Emerging Cell Therapies: Realizing the Vision of NextGen Cell Therapeutics | EK15

Jan 25, 2021 ‐ Jan 27, 2021



Sessions

Reprogramming Immune Cell Therapeutics with Non-Viral Gene Editing Approaches

Jan 25, 2021 5:00pm ‐ Jan 25, 2021 5:25pm

Speaker(s):
  • Alex Marson, MD, PhD, University of California, San Francisco

New Approaches for Programming Cellular Therapeutics

Jan 25, 2021 5:00pm ‐ Jan 25, 2021 8:00pm

Co-Chair(s):

Engineered Cytokines for Cancer Immunotherapy

Jan 25, 2021 5:25pm ‐ Jan 25, 2021 5:50pm

Speaker(s):

Expanding the Functional Capacity of Therapeutic Immune Cells

Jan 25, 2021 5:50pm ‐ Jan 25, 2021 6:15pm

Speaker(s):

Design of Eukaryotic Gene Regulatory Circuits

Jan 25, 2021 6:15pm ‐ Jan 25, 2021 6:40pm

Speaker(s):

Coffee Break iconCoffee Break

Preview Available

Coffee Break

Jan 25, 2021 6:40pm ‐ Jan 25, 2021 6:45pm


Short Talk: Elimination of Mouse B Cells by Non-Virally Engineered CAR19 Knock-In T Cells

Jan 25, 2021 6:45pm ‐ Jan 25, 2021 7:00pm

Speaker(s):

Short Talk: Engineering B Cells in-vivo Elicits Potent Cellular and Serological Responses in Mice

Jan 25, 2021 7:00pm ‐ Jan 25, 2021 7:15pm

Speaker(s):

Short Talk: Efficient Gene Knockout in Primary Myeloid Cells by Non-Viral Delivery of CRISPR-Cas9

Jan 25, 2021 7:15pm ‐ Jan 25, 2021 7:30pm

Speaker(s):

Short Talk: Microfluidic Cell Squeezing Enables the Generation of Novel Cell Therapies for Diverse Clinical Applications

Jan 25, 2021 7:30pm ‐ Jan 25, 2021 7:45pm

Speaker(s):